Defibrillators Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Defibrillator Market by Product type (Implantable Cardioverter Defibrillators (Single Chamber Implantable Cardioverter Defibrillator, Dual Chamber Implantable Cardioverter Defibrillator), External Defibrillator (Manual, Automated, Wearable), by End-user (Hospitals, Cardiac Clinics, Home Care, Others), and Geography.

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Defibrillators Market size valued 9.8 billion in 2021 and expected to reach USD 12.8 billion by 2028, at a CAGR of 3.8% during the forecast period 2022-2028. Heart muscles require continuous supply of blood for proper functioning. When the supply of blood to the artery is decreased cardiac arrhythmias and heart attack may occur. Blockage of coronary artery may occur due to improper impulse conduction or blood clot. If not treated immediately may lead to death.  Defibrillator used to prevent the sudden cardiac attack. Specially used for ventricular fibrillation and non perfusing ventricular tachycardia. These conditions occur due to the disruption of normal electrical impulse that controls the heart rate and pumping action. Defibrillator sends an electrical current to the heart which is used to restart the normal functioning of heart. Defibrillator treatment is given for the patients only when there is a high risk of sudden heart failure or sudden cardiac death. Normally Defibrillator used for outpatient. Many of the heart care associations and alliances are promoting to create awareness about cardiac conditions and to increase the survival rate of the patients are expected to show significant growth for defibrillator market during forecast period. For instance, in 2016, Global Resuscitation Alliance (GRA) was formed comprising of, global resuscitation leaders, international health organizations and American heart association (AHA). Defibrillator market is very dynamic in nature. Defibrillator market is dominated by very few players. To enhance their sales revenue companies are inorganic growth strategies such as adopting mergers and acquisitions. In addition, companies are betting heavily on R&D to develop new technologies.

Key Developments:

In July 2016, Life-Assist, Inc. Partnered with Koninklijke Philips N.V. to distribute its automated external defibrillators and patient monitors in the western U.S.

In May 2016 U.S. FDA approved Medtronic’s Visia AF single-chamber implantable cardioverter defibrillators for tachycardia management

Defibrillators Market

MARKET SUMMARY
-
3.8% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 3.8%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Defibrillators Market

  • The report on global defibrillators market gives historical, current and future market sizes (US$ Mn) based on product type, end user and geographical regions.
  • defibrillators market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Abbott Laboratories
  • BIOTRONIK SE & Co. KG
  • LivaNova PLC
  • Physio-Control, Inc.
  • Nihon Kohden Corporation
  • Koninklijke Philips N.V.
Defibrillators Market Dynamics

Defibrillator market growth is driven by rapidly growing geriatric patients who are very susceptible to cardiac diseases, technological advancements in defibrillators, growing awareness in sudden cardiac arrest, and increased incidents of cardiac diseases. Two of the most important advancements are development of automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD). However, factors such as frequent product recalls, increase in pricing pressure on players, and lack of awareness about sudden cardiac arrest (SCA)


North-America Got Significant Share

Defibrillators Market

Geographically defibrillator market is segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is expected to major share in defibrillator market mainly due to the well-established healthcare infrastructure and increase in incidence of cardiac diseases and obesity. Furthermore, growing awareness about sudden cardiac arrest and other heart diseases in the U.S. contribute are expected to drive defibrillator growth in North America region. Asia-Pacific region is expected to be fastest growing due to increased obese patients, people with cardiac diseases, rapid development in healthcare infrastructure coupled with increased government spending and public spending on healthcare especially in emerging markets like India and China. Increase in awareness about utility of defibrillators in the Middle-East, especially in U.A.E and the support from government is contributing to growth of defibrillators market in Middle East and Africa region

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share and forecast from 2022-2028
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Defibrillators Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive summary

2. Global Defibrillators Market Introduction

      2.1. Global Defibrillators Market– Taxonomy
      2.2. Global Defibrillators Market–Definitions
            2.2.1. End User

            2.2.2. Product Type

3. Global Defibrillators Market Dynamics

      3.1. Drivers
      3.2. Restraints
      3.3. Opportunities/Unmet Needs of the Market
      3.4. Trends
      3.5. Global Defibrillators Market Dynamics – Factors Impact Analysis

      3.6. Global Defibrillators Market– Recent Market Introductions

4. Global Defibrillators Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024

      4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

      4.3. Market Oppurtunity Analysis

5. Global Defibrillators Market Forecast, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024

      5.1. Implantable Cardioverter Defibrillators
            5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.1.3. Market Opportunity Analysis
      5.2. External Defibrillator
            5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

            5.2.3. Market Opportunity Analysis

6. Global Defibrillators Market Forecast, By End User, 2013 – 2017 and Forecast, 2018 – 2024

      6.1. Hospitals
            6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.1.3. Market Opportunity Analysis
      6.2. Cardiac Clinics
            6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.2.3. Market Opportunity Analysis
      6.3. Home Care
            6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

            6.3.3. Market Opportunity Analysis

7. Global Defibrillators Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024

      7.1. North America
            7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.1.3. Market Opportunity Analysis
      7.2. Europe
            7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.2.3. Market Opportunity Analysis
      7.3. Asia-Pacific
            7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.3.3. Market Opportunity Analysis
      7.4. Latin America
            7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.4.3. Market Opportunity Analysis
      7.5. Middle East and Africa
            7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
            7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.5.3. Market Opportunity Analysis

      7.6. Global Defibrillators Market- Opportunity Analysis Index – By Product Type, By End User, and Region, 2018 – 2024

8. North America Defibrillators Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024

      8.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            8.1.1. Implantable Cardioverter Defibrillators
                        8.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
                        8.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
            8.1.2. External Defibrillator
                        8.1.2.1. Manual
                        8.1.2.2. Automated
                        8.1.2.3. Wearable
      8.2. End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            8.2.1. Hospitals
            8.2.2. Cardiac Clinics
            8.2.3. Home Care
      8.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
            8.3.1. U.S.
            8.3.2. Canada
      8.4. North America Defibrillators Market- Opportunity Analysis Index – By Product Type, By End User, and Country, 2018 – 2024

      8.5. North America Defibrillators Market Dynamics – Trends

9. Europe Defibrillators Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024

      9.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            9.1.1. Implantable Cardioverter Defibrillators
                        9.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
                        9.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
            9.1.2. External Defibrillator
                        9.1.2.1. Manual
                        9.1.2.2. Automated
                        9.1.2.3. Wearable
      9.2. End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            9.2.1. Hospitals
            9.2.2. Cardiac Clinics
            9.2.3. Home Care
      9.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            9.3.1. Germany
            9.3.2. UK
            9.3.3. France
            9.3.4. Spain
            9.3.5. Italy
            9.3.6. Russia
            9.3.7. Poland
            9.3.8. Rest of Europe
      9.4. Europe Defibrillators Market- Opportunity Analysis Index – By Product Type, By End User, and Country, 2018 – 2024

      9.5. Europe Defibrillators Market Dynamics – Trends

10. Asia-Pacific Defibrillators Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024

      10.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            10.1.1. Implantable Cardioverter Defibrillators
                        10.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
                        10.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
            10.1.2. External Defibrillator
                        10.1.2.1. Manual
                        10.1.2.2. Automated
                        10.1.2.3. Wearable
      10.2. End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            10.2.1. Hospitals
            10.2.2. Cardiac Clinics
            10.2.3. Home Care
      10.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            10.3.1. Japan
            10.3.2. China
            10.3.3. India
            10.3.4. ASEAN
            10.3.5. Australia & New Zealand
            10.3.6. Rest of Asia-Pacific
      10.4. Asia-Pacific Defibrillators Market- Opportunity Analysis Index – By Product Type, By End User, and Country, 2018 – 2024

      10.5. Asia-Pacific Defibrillators Market Dynamics – Trends

11. Latin America Defibrillators Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024

      11.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            11.1.1. Implantable Cardioverter Defibrillators
                        11.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
                        11.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
            11.1.2. External Defibrillator
                        11.1.2.1. Manual
                        11.1.2.2. Automated
                        11.1.2.3. Wearable
      11.2. End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            11.2.1. Hospitals
            11.2.2. Cardiac Clinics
            11.2.3. Home Care
      11.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            11.3.1. Brazil
            11.3.2. Mexico
            11.3.3. Argentina
            11.3.4. Venezuela
            11.3.5. Rest of Latin America
      11.4. Latin America Defibrillators Market- Opportunity Analysis Index – By Product Type, End User, and Country, 2018 – 2024

      11.5. Latin America Defibrillators Market Dynamics – Trends

12. Middle East & Africa Defibrillators Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024

      12.1. Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            12.1.1. Implantable Cardioverter Defibrillators
                        12.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
                        12.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
            12.1.2. External Defibrillator
                        12.1.2.1. Manual
                        12.1.2.2. Automated
                        12.1.2.3. Wearable
      12.2. End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            12.2.1. Hospitals
            12.2.2. Cardiac Clinics
            12.2.3. Home Care
      12.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            12.3.1. Gulf Cooperation Council (GCC) Countries
            12.3.2. Israel
            12.3.3. South Africa
            12.3.4. Rest of MEA
      12.4. MEA Defibrillators Market- Opportunity Analysis Index – By Product Type, By End User, and Country, 2018 – 2024

      12.5. MEA Defibrillators Market Dynamics – Trends

13. Competition Landscape

      13.1. Strategic Dashboard of Top Market Players
      13.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
            13.2.1. Medtronic (U.S.)
            13.2.2. Abbott Laboratories (U.S.)
            13.2.3. Asahi Kasei Corporation (ZOLL Medical Corporation) (Japan)
            13.2.4. LivaNova PLC (U.K)
            13.2.5. Physio-Control, Inc. (U.S.)
            13.2.6. Nihon Kohden Corporation (Japan)
            13.2.7. BIOTRONIK SE & Co. KG (Germany)
            13.2.8. Koninklijke Philips N.V. (Netherlands)

            13.2.9. Boston Scientific Corporation(U.S.)

14. Research Methodology

15. Key Assumptions and Acronyms


Report

Company Profile

  • Medtronic (U.S.)
  • Abbott Laboratories (U.S.)
  • Asahi Kasei Corporation (ZOLL Medical Corporation) (Japan)
  • LivaNova PLC (U.K)
  • Physio-Control, Inc. (U.S.)
  • Nihon Kohden Corporation (Japan)
  • BIOTRONIK SE & Co. KG (Germany)
  • Koninklijke Philips N.V. (Netherlands)
  • Boston Scientific Corporation(U.S.)

Description

Defibrillators Market size valued 9.8 billion in 2021 and expected to reach USD 12.8 billion by 2028, at a CAGR of 3.8% during the forecast period 2022-2028. Heart muscles require continuous supply of blood for proper functioning. When the supply of blood to the artery is decreased cardiac arrhythmias and heart attack may occur. Blockage of coronary artery may occur due to improper impulse conduction or blood clot. If not treated immediately may lead to death.  Defibrillator used to prevent the sudden cardiac attack. Specially used for ventricular fibrillation and non perfusing ventricular tachycardia. These conditions occur due to the disruption of normal electrical impulse that controls the heart rate and pumping action. Defibrillator sends an electrical current to the heart which is used to restart the normal functioning of heart. Defibrillator treatment is given for the patients only when there is a high risk of sudden heart failure or sudden cardiac death. Normally Defibrillator used for outpatient. Many of the heart care associations and alliances are promoting to create awareness about cardiac conditions and to increase the survival rate of the patients are expected to show significant growth for defibrillator market during forecast period. For instance, in 2016, Global Resuscitation Alliance (GRA) was formed comprising of, global resuscitation leaders, international health organizations and American heart association (AHA). Defibrillator market is very dynamic in nature. Defibrillator market is dominated by very few players. To enhance their sales revenue companies are inorganic growth strategies such as adopting mergers and acquisitions. In addition, companies are betting heavily on R&D to develop new technologies.

Key Developments:

In July 2016, Life-Assist, Inc. Partnered with Koninklijke Philips N.V. to distribute its automated external defibrillators and patient monitors in the western U.S.

In May 2016 U.S. FDA approved Medtronic’s Visia AF single-chamber implantable cardioverter defibrillators for tachycardia management

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX